GU Cancers 2020 | Prostate active surveillance

VJOncology is committed to improving our service to you

Jeff Tosoian

Jeff Tosoian, MD, MPH, Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, discusses the use of active surveillance for the management of men with grade group 1 (GG1) prostate cancer. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter